Therefore, high levels of sPLA2‐V drove anti‐obesity and anti‐inflammatory effects and high levels of sPLA2‐IIE led to the opposite effect (Sato et al., 2016). The gene discussed is PLA2G2A; the disease is obesity due to melanocortin 4 receptor deficiency.